Home/Pipeline/Family Biobanking (Cord Blood/Tissue)

Family Biobanking (Cord Blood/Tissue)

Future autologous/familial use in >80 established diseases & regenerative applications

CommercialActive

Key Facts

Indication
Future autologous/familial use in >80 established diseases & regenerative applications
Phase
Commercial
Status
Active
Company

About Swiss Stem Cells Biotech

Swiss Stem Cells Biotech AG is a pioneering Swiss biobank leveraging its FACT-NetCord and GMP certifications to provide high-quality, in-country stem cell preservation services. Its core business revolves around family banking for umbilical cord and adipose tissue-derived stem cells, complemented by a unique hybrid banking model that bridges private storage and public donation. The company has expanded its service portfolio to include DNA storage, immune cell preservation, and ATMP contract manufacturing, aiming to be a full-service partner in the regenerative medicine value chain. Founded in 2005 and headquartered in Geneva, SSCB combines rigorous Swiss regulatory standards with a strategic focus on both therapeutic applications and research.

View full company profile